Quarterly earnings results are a good time to check in on a company’s progress, especially compared to its peers in the same ...

GAAP earnings came in at $1.99 per share, up 1.5% from last year’s comparable figure. DGX’s Q3 in Detail Revenues reported in the third quarter rose 8.4% year over year to $2.49 billion. The ...

DGX outperforms the industry and the S&P 500 ... Key Insights Using the 2 Stage Free Cash Flow to Equity, Quest Diagnostics fair value estimate is US$339 Current share... Bio-Rad witnesses growth ...

No. 1: It is already the case that we’re selling DGX Cloud today, and there is a model for it to be transacted through the NPN. So that’s already in place. And No. 2: Of course, these are ...